Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The widespread application of intestinal transplantation depends upon achieving a success rate sufficiently high to warrant treating patients by transplantation rather than parenteral nutrition. This is analogous to the situation in renal transplantation (where the alternative is dialysis) and pancreatic transplantation (insulin treatment) and contrasts with the situation in liver and heart transplantation where there is no effective alternative therapy. The main barrier to success at this level is immunological; progress will depend on improved prevention, diagnosis and treatment of rejection. Although developments are expected of new and more potent immunosuppressive drugs, it is possible that acceptable long-term results will require a more fundamental manipulation of the immune response in order to achieve at least partial tolerance of the graft.

Original publication

DOI

10.1093/oxfordjournals.bmb.a011648

Type

Journal article

Journal

Br Med Bull

Publication Date

1997

Volume

53

Pages

789 - 797

Keywords

Graft Rejection, Humans, Intestine, Small, Parenteral Nutrition, Patient Selection